MedPath

ANASTROZOLE

ANASTROZOLE

Approved
DIN Number

02529904

Drug Class

Human

Market Date

Jul 6, 2023

Company
HC

sivem pharmaceuticals ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529904
AIG Number0128681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG03 ANASTROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANASTROZOLEActive
Strength: 1 MG
Monograph: ANASTROZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.